Please use this identifier to cite or link to this item:
https://doi.org/10.1093/jjco/hyw185
Title: | A review of prognostic scores after liver resection in hepatocellular carcinoma: The MSKCC, SLICER and SSCLIP scores | Authors: | Chan, E.E Chow, P.K.-H |
Keywords: | adult aged cancer prognosis cancer recurrence Child Pugh score controlled study demography ethnicity female human intermethod comparison liver cell carcinoma liver resection major clinical study male Memorial Sloan Kettering Cancer Center Score prognostic assessment Review scoring system Singapore Liver Cancer Recurrence Score SSCLIP scoring system validation study very elderly Carcinoma, Hepatocellular cohort analysis Liver Neoplasms liver resection middle aged mortality pathology prognosis survival analysis Adult Aged Aged, 80 and over Carcinoma, Hepatocellular Cohort Studies Female Hepatectomy Humans Liver Neoplasms Male Middle Aged Prognosis Survival Analysis |
Issue Date: | 2017 | Publisher: | Oxford University Press | Citation: | Chan, E.E, Chow, P.K.-H (2017). A review of prognostic scores after liver resection in hepatocellular carcinoma: The MSKCC, SLICER and SSCLIP scores. Japanese Journal of Clinical Oncology 47 (4) : 287-293. ScholarBank@NUS Repository. https://doi.org/10.1093/jjco/hyw185 | Rights: | Attribution 4.0 International | Abstract: | Predicting prognosis in hepatocellular carcinoma (HCC) aids clinical decision-making and stratifies patient follow-up plans. There are currently three prognostic scores specific to liver resection of HCC published in the literature: the MSKCC, SLICER and SSCLIP scores. In this review, we highlight the methodology employed in the construction of these scores and discuss the strengths and weaknesses of each. Current limitations to prognostic scores include the inability to differentiate between early and late recurrences of HCC, the failure to account for the impact of aetiology of HCC and the assumption that ethnicity has no impact on disease process. Further scientific discoveries in these areas will allow for improvement in prognostication. The SLICER score is currently the most comprehensive. External validation of each score in cohorts of patients with different baseline demographics and clinical characteristics will be required to examine their stability and reliability. © The Author 2017. Published by Oxford University Press. | Source Title: | Japanese Journal of Clinical Oncology | URI: | https://scholarbank.nus.edu.sg/handle/10635/179260 | ISSN: | 0368-2811 | DOI: | 10.1093/jjco/hyw185 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1093_jjco_hyw185.pdf | 385.3 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License